Cleveland Clinic-Led Trial Shows Dual-Chamber Leadless Pacemaker System to be Safe and Effective For Patients with Heart Rhythm Issues
Findings from a Cleveland Clinic-led clinical trial which assessed the safety and performance of a dual-chamber leadless pacemaker system in humans showed that the device met the primary safety and performance study goals and provided heart pacing support and reliable timing between atrial and ventricular activity for 3 months after implantation.
May 22, 2023
Remote Blood Pressure Monitoring After Pregnancy May Stave Off Postpartum Health Issues for Women with Preeclampsia
New mothers with high blood pressure who participated in a post-partum remote blood pressure monitoring program were less likely to have post-partum complications, hospitalizations, and incurred less health care costs in the six months after delivery compared to mothers with high blood pressure who did not participate, according to a multi-year study from the Perelman School of Medicine at the University of Pennsylvania.
May 12, 2023
Photo 124522379 / Medical © Spettacolare | Dreamstime.com
Mount Sinai Researchers Describe Urgent Need for Data on Quality of Care Offered by Medicare Advantage Plans
As Medicare Advantage plans enroll more and more patients with serious illness, it is not clear how well the plans take care of these patients, Mount Sinai researchers say in a Perspective piece published in the New England Journal of Medicine.
May 12, 2023
Photo 73783413 / Medical © Mira Agron | Dreamstime.com
The first-ever randomized clinical trial linked to registry data from the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) shows that for patients undergoing pancreatoduodenectomy, also known as the Whipple procedure, a change in antibiotics before the procedure reduces the rate of surgical site infections (SSIs). The findings were published recently in the Journal of the American Medical Association (JAMA).
$2.5 Million Grant Supports Specialized Geriatric Cancer Care at Penn Medicine Princeton Health
The Penn Medicine Princeton Cancer Center received a $2.5 million grant from the Bristol Myers Squibb Foundation to help fund an innovative program to ensure holistic, patient-centered care for older adults with cancer.
Alert Banners Dramatically Increase Prescribing Rates of Lifesaving Heart Failure Medication
An automated system that flags the patients who could most benefit from an underused yet lifesaving cardiology drug more than doubled new prescriptions, according to a pilot program test by researchers at NYU Grossman School of Medicine. “Our findings suggest that tailored electronic notifications can boost the prescription of lifesaving drugs,” said study lead author and cardiologist Amrita Mukhopadhyay, MD, a clinical instructor in the Department of Medicine. “By compiling key information in one place, the system may help providers spend less time searching through medical records during a visit and more time speaking with their patients.”
Melax Tech and Boston Academic Center Hospital Awarded $2.5 Million Joint Grant from the National Institute of Health (NIH)
Melax Tech, a provider of biomedical natural language processing (NLP) technology, and Brigham and Women’s Hospital, an academic medical center in Boston, has been awarded a two-year $2.5 million grant by the NIH. The project aims to build and validate a clinical decision support system (CDS) for early cognitive decline detection. The study will use advanced deep learning and NLP algorithms to identify patients with cognitive decline signals from electronic health records (EHRs) and improve early diagnosis in primary care settings.